Dr Nii Hanson-Nortey, Consultant international en tuberculose, VIH et sécurité sanitaire mondiale La tuberculose (TB) reste un défi majeur de santé en Afrique, avec des…
Tuberculosis (TB) remains a major health challenge in Africa, with funding uncertainties threatening progress. In this interview, Dr. Nii Hanson-Nortey, a leading TB expert from…
From Commitment to Action "The Lusaka Agenda has moved from rhetoric to action. Countries are embedding its principles into national policies, strengthening primary health care,…
Introduction Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, despite being preventable and curable. While significant progress has been made in the global…
The Office of the Inspector General (OIG) is an important part of the Global Fund to Fight AIDS, Tuberculosis, and Malaria. It is tasked with…
The 19th Organisation Internationale de la Francophonie (OIF) Summit occurred in Paris, France, on the 7th and 9th of October 2024. During the same week,…
The Global Fund Board established the Additional Safeguard Policy (ASP) in 2004 as an approach for alternative funding mechanisms where particular constraints about funding Principal…
Introduction Long-acting injectable ARVs are a major breakthrough in HIV prevention and treatment. They are used as pre-exposure prophylaxis for HIV-negative people, particularly those at…
Context The UNAIDS 95-95-95 targets are a set of ambitious goals aimed at ending the AIDS epidemic by 2030. The first of these targets is…
In May this year, the Office of the Inspector General (OIG) published an audit report of the Global Fund’s approach to grant monitoring. The report…